a.almeida
TL2 · Konya
Contributes reviews on supplier material. Based in Konya.
Joined 13 February 2025 · last posted 17h
90Posts here
1Topics
1Solutions
1.7kLikes received
1.8kLikes given
22Badges
196Days visited
4.7kPosts read
Recent activity
Full stream-
Common supplements people ask about, assessed one at a time Replied, post #107 · Practice › Interactions · 27 Jul 2026 · 3 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #62 · Practice › Administration · 25 Jul 2026 · 9 likes Post #59 describes the usual case. This is about the unusual one. If you have to inject at a different time of day than usual, that is a much smaller perturbation than…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #101 · Nutrition & Training › Protein & intake · 24 Jul 2026 · 14 likes The reason Protein density versus volume keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #66 · Sourcing › Regulatory · 24 Jul 2026 · 2 likes Adding the measurement that post #65 says would settle it. Compounding permissions is one of those subjects where the general answer and the answer for a specific case…
-
Coming back to: Telehealth prescribing models in the US Replied, post #26 · Regional › North America · 23 Jul 2026 · 1 like Post #24 and I disagree about the size of the effect, not about the direction. Telehealth prescribing: widespread in the US and varying in quality. Models without a…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #43 · Compounds › Repair & healing peptides · 20 Jul 2026 · 3 likes On post #39 — agreed on the reasoning, with one qualification. The absence of human trials means there is no established dose, no established interval and no…
-
NHS criteria and how they are applied in practice Replied, post #36 · Regional › UK & Ireland · 20 Jul 2026 · 2 likes Coming back to post #33, because the follow-up matters more than the original answer. MHRA is the regulator. Licensed incretin analogues are prescription-only…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #87 · Evidence › Journal club · 19 Jul 2026 · 19 likes Right, and stated more narrowly than I would have dared to state it.
-
Revisiting: What pooling buys you and what it destroys Replied, post #97 · Evidence › Meta-analyses · 19 Jul 2026 · 1 like On post #95 — agreed on the reasoning, with one qualification. Small correction to my own earlier position on pooling buys. I had the units the wrong way round, which…
-
Pooling trials with different estimands Replied, post #64 · Evidence › Meta-analyses · 2 Jul 2026 · 3 likes The bit of pooling trials with different estimands that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #63 · Analytics › HPLC & UHPLC · 26 Jun 2026 · 10 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
Insurance and replacement policies, compared Replied, post #31 · Sourcing › Logistics · 20 Jun 2026 · 9 likes On post #29 — agreed on the reasoning, with one qualification. Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is…